http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112501073-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-02 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-02 |
| filingDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112501073-B |
| titleOfInvention | Bacillus marinus SWGC31 and culture method and application thereof |
| abstract | The invention provides a bacillus marinus SWGC31 strain and a culture method and application thereof, belonging to the technical field of functional bacteria development. Bacillus marinus (Bacillus aquimaris) for biologically catalyzing and synthesizing L-xylose, SWGC31, and the preservation number is CGMCC No. 13351. The strain is a new strain which can catalyze and synthesize L-xylose by taking 2-keto-L-gulonic acid as a substrate, the strain can express and generate decarboxylase, the preparation of the L-xylose with high purity can be realized by the strain, the conversion rate is 100%, and the optical purity reaches 100%. The strain is used for carrying out the asymmetric reduction process, the reaction condition is mild, the energy is saved, the environment is protected, more importantly, the economic benefit of the L-xylose is obviously improved, and the strain has good industrial application prospect. |
| priorityDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.